Primary brain tumours in adults, The Lancet, vol.379, issue.9830, pp.1984-96, 2012. ,
DOI : 10.1016/S0140-6736(11)61346-9
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-66, 2009. ,
DOI : 10.1016/S1470-2045(09)70025-7
Central Nervous System Tumors, Mayo Clinic Proceedings, vol.82, issue.10, pp.1271-86, 2007. ,
DOI : 10.4065/82.10.1271
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, vol.8, issue.7120, pp.756-60, 2006. ,
DOI : 10.1038/nature05236
Identification of a cancer stem cell in human brain tumors, Cancer Res, vol.63, issue.18, pp.5821-814522905, 2003. ,
Identification of human brain tumour initiating cells, Nature, vol.64, issue.7015, pp.396-401, 2004. ,
DOI : 10.1038/nature03128
Isolation of cancer stem cells from adult glioblastoma multiforme, Oncogene, vol.23, issue.58, pp.9392-9400, 2004. ,
DOI : 10.1038/sj.onc.1208311
Overview of cellular immunotherapy for 18 patients with glioblastoma, Clin. Dev. Immunol. Article ID, vol.2010, issue.18, p.689171, 2010. ,
Cellular immunotherapy for high-grade glioma, Immunotherapy, vol.3, issue.3, pp.423-457, 2011. ,
DOI : 10.2217/imt.10.110
Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy, Brain, vol.135, issue.4, pp.1042-54, 2012. ,
DOI : 10.1093/brain/aws042
Emerging monoclonal antibody therapies for malignant gliomas, Expert Opinion on Investigational Drugs, vol.5, issue.4, pp.477-94, 2007. ,
DOI : 10.1097/00006123-199711000-00005
A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy, Journal of Immunology Research, vol.164, issue.7, p.326545, 2014. ,
DOI : 10.1038/nm1100
A nomenclature to fit the organization of the human T-cell receptor ?? and ?? genes, Research in Immunology, vol.141, issue.6, pp.615-80923, 1990. ,
DOI : 10.1016/0923-2494(90)90068-A
???? T cells in cancer, Nature Reviews Immunology, vol.45, issue.11, pp.683-91, 2015. ,
DOI : 10.1038/nri3904
Human V??9V??2 T cells: promising new leads for immunotherapy of infections and tumors, Current Opinion in Immunology, vol.18, issue.5, pp.539-585, 2006. ,
DOI : 10.1016/j.coi.2006.07.002
EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid, In vivo, vol.28, issue.5, pp.1001-425189922, 2014. ,
What lessons can be learned from ???? T cell-based cancer immunotherapy trials?, Cellular and Molecular Immunology, vol.8, issue.1, pp.35-41, 2013. ,
DOI : 10.1038/cmi.2012.39
Repeated systemic administrations of both aminobisphosphonates and human Vgamma9Vdelta2 T cells efficiently control tumor development in vivo, J. Immunol, vol.191, issue.4, 1993. ,
Cytotoxic human peripheral blood-derived ????T cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma, Journal of Neuro-Oncology, vol.5, issue.1, pp.31-924062140, 2014. ,
DOI : 10.1007/s11060-013-1258-4
Zoledronic Acid Enhances V??2 T-Lymphocyte Antitumor Response to Human Glioma Cell Lines, International Journal of Immunopathology and Pharmacology, vol.20, issue.1, pp.139-4821496396, 2011. ,
DOI : 10.1177/039463201102400116
Identification of c-Kit receptor as a regulator of adult neural stem cells in the mammalian eye: interactions with Notch signaling, Developmental Biology, vol.273, issue.1, pp.87-105, 2004. ,
DOI : 10.1016/j.ydbio.2004.05.023
Identification of new CNS-resident macrophage subpopulation molecular markers for the discrimination with murine systemic macrophages, Journal of Neuroimmunology, vol.169, issue.1-2, pp.39-49, 2005. ,
DOI : 10.1016/j.jneuroim.2005.07.016
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human ???? T-cell subset, Blood, vol.120, issue.11, pp.2269-79, 2012. ,
DOI : 10.1182/blood-2012-05-430470
Radiation-induced PGE2 sustains human glioma cells growth and survival through EGF signaling, Oncotarget, vol.6, issue.9, pp.6840-6849, 2015. ,
DOI : 10.18632/oncotarget.3160
Targeting Cancer Stem Cells for Treatment of Glioblastoma Multiforme, Cell Transplantation, vol.22, issue.4, pp.731-740, 2013. ,
DOI : 10.3727/096368912X655136
Presence of pluripotent CD133+ cells correlates with malignancy of gliomas, Molecular and Cellular Neuroscience, vol.43, issue.1, pp.51-60, 2010. ,
DOI : 10.1016/j.mcn.2008.07.022
Chondroitin Sulfate Proteoglycans Potently Inhibit Invasion and Serve as a Central Organizer of the Brain Tumor Microenvironment, Journal of Neuroscience, vol.33, issue.39, pp.15603-173004, 2013. ,
DOI : 10.1523/JNEUROSCI.3004-12.2013
Nonpeptide antigens, presentation mechanisms, and immunological memory of human V??2V??2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens, Immunological Reviews, vol.151, issue.16, pp.59-76, 2007. ,
DOI : 10.1002/eji.1830220506
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human V??9V??2??T Cells, Immunity, vol.40, issue.4, pp.490-500, 2014. ,
DOI : 10.1016/j.immuni.2014.03.003
The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation, Cancer Immunology, Immunotherapy, vol.176, issue.5, pp.551-62, 2015. ,
DOI : 10.1007/s00262-015-1662-z
Human ????+ T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response, Bone Marrow Transplantation, vol.27, issue.6, pp.601-607, 2001. ,
DOI : 10.1038/sj.bmt.1702830
Innate and Adaptive Immune Responses of the Central Nervous System, Critical Reviews??? in Immunology, vol.26, issue.2, pp.149-88, 2006. ,
DOI : 10.1615/CritRevImmunol.v26.i2.40
Structural and functional features of central nervous system lymphatic vessels, Nature, vol.14, issue.7560, pp.337-378, 2015. ,
DOI : 10.1038/nature14432
Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situ T???cell activation and therapeutic efficacy, 9999%3c::AID-IJC1038%3e3.3.CO, pp.225-255, 2001. ,
DOI : 10.1002/1097-0215(200002)9999:9999<::AID-IJC1038>3.3.CO;2-7
Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas, Journal of Neuro-Oncology, vol.45, issue.2, pp.141-5710778730, 1999. ,
DOI : 10.1023/A:1006293606710
Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony???stimulating factor and adoptive transfer of anti-CD3???activated lymphocytes, Neurosurgical Focus, vol.9, issue.6, 2000. ,
DOI : 10.3171/foc.2000.9.6.10
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial, The Lancet Oncology, vol.14, issue.9, pp.823-856, 2013. ,
DOI : 10.1016/S1470-2045(13)70274-2
Biochemical and molecular mechanisms of action of bisphosphonates, Bone, vol.49, issue.1, pp.34-41, 2011. ,
DOI : 10.1016/j.bone.2010.11.008
Phase I/II study of adoptive transfer of ???? T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma, Cancer Immunology, Immunotherapy, vol.30, issue.Suppl 1, pp.1075-84, 2011. ,
DOI : 10.1007/s00262-011-1021-7
Risks and benefits of bisphosphonates, British Journal of Cancer, vol.2, issue.11, pp.1736-1776, 2008. ,
DOI : 10.1093/jnci/djm025
Biodistribution and Plasma Protein Binding of Zoledronic Acid, Drug Metabolism and Disposition, vol.36, issue.10, pp.2043-918625688, 2008. ,
DOI : 10.1124/dmd.108.021071
Requirement of Species-Specific Interactions for the Activation of Human ???? T Cells by Pamidronate, The Journal of Immunology, vol.170, issue.7, pp.3608-3621, 2003. ,
DOI : 10.4049/jimmunol.170.7.3608
Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells):e101260; PMID:24968029, PloS One, vol.9, issue.6, 2014. ,
Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion, Oncotarget, vol.4, issue.9, pp.1449-60, 2013. ,
DOI : 10.18632/oncotarget.1201